Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to $2.8 million.

  • MDxHealth's Change in Account Payables rose 82610.97% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 27148.2%. This contributed to the annual value of $458000.0 for FY2024, which is 219000.0% up from last year.
  • According to the latest figures from Q3 2025, MDxHealth's Change in Account Payables is $2.8 million, which was up 82610.97% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Change in Account Payables registered a high of $3.1 million during Q2 2022, and its lowest value of -$2.6 million during Q4 2024.
  • For the 4-year period, MDxHealth's Change in Account Payables averaged around $84444.4, with its median value being -$383000.0 (2024).
  • Data for MDxHealth's Change in Account Payables shows a peak YoY increase of 82610.97% (in 2025) and a maximum YoY decrease of 82610.97% (in 2025) over the last 5 years.
  • MDxHealth's Change in Account Payables (Quarter) stood at $11000.0 in 2021, then soared by 27918.18% to $3.1 million in 2022, then crashed by 183.23% to -$2.6 million in 2024, then surged by 208.42% to $2.8 million in 2025.
  • Its Change in Account Payables was $2.8 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$737000.0 in Q1 2025.